30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Protara Therapeutics Inc (TARA)

Track

Over the last 90 days, Protara Therapeutics Inc. has seen significant insider selling, totaling over $1.9 million, primarily from former affiliates. There were no insider purchases during this period. The stock price has declined approximately 28% in the past 90 days. The last earnings report showed a positive EPS beat of 16.2%.
Stock chart
Ticker: TARA Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Baker Brothers Life Sciences, L.P.
Former Affiliate
1 sale — total 1,605,942 USD
Proposed sale 23 Apr 2026
Value US$810,660.42 | Price 45.71 | Shares 77,487
Proposed sale 23 Apr 2026
Value US$1,822,424.24 | Price 252.18 | Shares 79,181
Planned sale 8 Apr 2026
Value US$6,123.60 | Price 5.40 | Shares 1,134
Planned sale 1 Apr 2026
Value US$118,865.48 | Price 5.26 | Shares 22,598
Proposed sale 1 Apr 2026
Value US$124,826.00 | Price 5.26 | Shares 23,732
Proposed sale 6 Mar 2026
Value US$223,920.00 | Price 5.85 | Shares 38,277
Proposed sale 6 Mar 2026
Value US$2,701,080.00 | Price 5.85 | Shares 461,723
Proposed sale 4 Mar 2026
Value US$220,151.00 | Price 6.26 | Shares 35,173
Proposed sale 4 Mar 2026
Value US$2,654,641.00 | Price 6.26 | Shares 424,125
Proposed sale 25 Feb 2026
Value US$457,046.00 | Price 5.81 | Shares 78,716
Proposed sale 25 Feb 2026
Value US$5,501,316.00 | Price 5.81 | Shares 947,479
Proposed sale 24 Feb 2026
Value US$161,584.00 | Price 6.04 | Shares 26,755
Proposed sale 24 Feb 2026
Value US$1,944,922.00 | Price 6.04 | Shares 322,039
Buy 14 May 2025
Value US$63,800.00 | Price 3.19 | Shares 20,000
Planned sale 26 Mar 2025
Value US$96,144.72 | Price 4.53 | Shares 21,224
Proposed sale 26 Mar 2025
Value US$96,569.00 | Price 4.55 | Shares 21,224
Sale 12 Sep 2024
Value US$11,107.85 | Price 1.71 | Shares 6,500
Sale 12 Sep 2024
Value US$204,727.93 | Price 1.71 | Shares 119,801
Sale 11 Sep 2024
Value US$2,742.56 | Price 1.71 | Shares 1,600
Sale 11 Sep 2024
Value US$53,137.10 | Price 1.71 | Shares 31,000
Sale 10 Sep 2024
Value US$2,653.50 | Price 1.77 | Shares 1,500
Sale 10 Sep 2024
Value US$42,456.00 | Price 1.77 | Shares 24,000
Sale 9 Sep 2024
Value US$3,599.93 | Price 1.89 | Shares 1,900
Sale 9 Sep 2024
Value US$65,541.46 | Price 1.89 | Shares 34,592
Sale 16 Jul 2024
Value US$8,546.65 | Price 2.44 | Shares 3,500
Sale 16 Jul 2024
Value US$19,281.24 | Price 2.44 | Shares 7,896
Sale 11 Jul 2024
Value US$36,051.00 | Price 2.40 | Shares 15,000
Sale 11 Jul 2024
Value US$79,295.38 | Price 2.40 | Shares 32,993
Sale 10 Jul 2024
Value US$11,540.00 | Price 2.31 | Shares 5,000
Sale 10 Jul 2024
Value US$30,144.79 | Price 2.31 | Shares 13,061
Sale 9 Jul 2024
Value US$5,534.50 | Price 2.21 | Shares 2,500
Sale 9 Jul 2024
Value US$13,276.16 | Price 2.21 | Shares 5,997
Sale 1 Jul 2024
Value US$5,308.25 | Price 2.12 | Shares 2,500
Sale 1 Jul 2024
Value US$12,289.66 | Price 2.12 | Shares 5,788
Sale 28 Jun 2024
Value US$10,374.00 | Price 2.07 | Shares 5,000
Sale 28 Jun 2024
Value US$26,959.95 | Price 2.07 | Shares 12,994
Sale 27 Jun 2024
Value US$28,160.77 | Price 2.26 | Shares 12,471
Sale 27 Jun 2024
Value US$77,007.98 | Price 2.26 | Shares 34,103
Sale 25 Jun 2024
Value US$14,056.67 | Price 2.26 | Shares 6,225
Sale 25 Jun 2024
Value US$14,677.65 | Price 2.26 | Shares 6,500
Sale 31 May 2024
Value US$16,894.84 | Price 2.90 | Shares 5,824
Sale 30 May 2024
Value US$27,113.12 | Price 2.94 | Shares 9,230
Sale 22 May 2024
Value US$1,501.05 | Price 3.00 | Shares 500
Sale 22 May 2024
Value US$28,095.30 | Price 3.02 | Shares 9,300
Sale 21 May 2024
Value US$5,500.26 | Price 3.06 | Shares 1,800
Sale 21 May 2024
Value US$95,337.84 | Price 3.06 | Shares 31,200
Sale 17 May 2024
Value US$3,672.72 | Price 3.06 | Shares 1,200
Sale 17 May 2024
Value US$9,152.28 | Price 3.33 | Shares 2,750
Sale 17 May 2024
Value US$60,247.91 | Price 3.06 | Shares 19,685
Sale 17 May 2024
Value US$157,252.72 | Price 3.33 | Shares 47,250
Sale 10 May 2024
Value US$472,424.14 | Price 3.11 | Shares 151,700
Sale 9 May 2024
Value US$94,526.46 | Price 3.09 | Shares 30,600
Buy 15 Sep 2022
Value US$8,740.00 | Price 3.80 | Shares 2,300
Buy 15 Sep 2022
Value US$19,000.00 | Price 3.80 | Shares 5,000
Buy 14 Sep 2022
Value US$9,950.00 | Price 3.98 | Shares 2,500
Buy 14 Sep 2022
Value US$56,118.00 | Price 3.98 | Shares 14,100
Buy 11 Aug 2022
Value US$34,809.60 | Price 3.84 | Shares 9,065
Buy 30 Jun 2022
Value US$31,000.00 | Price 3.10 | Shares 10,000
Buy 8 Apr 2022
Value US$11,840.83 | Price 4.80 | Shares 2,469
Buy 8 Apr 2022
Value US$25,523.25 | Price 4.80 | Shares 5,322
Buy 7 Apr 2022
Value US$4,743.20 | Price 4.74 | Shares 1,000
Buy 7 Apr 2022
Value US$6,379.60 | Price 4.74 | Shares 1,345
Buy 14 Mar 2022
Value US$42,500.00 | Price 4.25 | Shares 10,000
Buy 10 Mar 2022
Value US$44,555.00 | Price 4.46 | Shares 10,000
Buy 28 Jan 2022
Value US$20,006.66 | Price 4.96 | Shares 4,031
Buy 28 Jan 2022
Value US$99,264.00 | Price 4.96 | Shares 20,000
Buy 20 Dec 2021
Value US$4,562.47 | Price 6.49 | Shares 703
Buy 17 Dec 2021
Value US$3,234.00 | Price 6.60 | Shares 490
Buy 17 Dec 2021
Value US$15,180.00 | Price 6.60 | Shares 2,300
Buy 16 Dec 2021
Value US$6,814.68 | Price 6.41 | Shares 1,063
Buy 16 Dec 2021
Value US$41,670.20 | Price 6.41 | Shares 6,500
Buy 18 Nov 2021
Value US$6,979.50 | Price 6.98 | Shares 1,000
Buy 18 Nov 2021
Value US$99,150.78 | Price 6.98 | Shares 14,206
Buy 17 Nov 2021
Value US$7,608.20 | Price 6.98 | Shares 1,090
Buy 17 Nov 2021
Value US$56,035.44 | Price 6.98 | Shares 8,028
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-04-23 2026-04-23 PrS Proposed sale
Baker Brothers Life Sciences, L.P.

Former Affiliate
77,487
45.71
US$810,660 		77,487 45.71 US$810,660
2026-04-23 2026-04-23 PrS Proposed sale
667, L.P.

Former Affiliate
79,181
252.18
US$1,822,424 		79,181 252.18 US$1,822,424
2026-04-09 2026-04-08 PlS Planned sale
Zummo Jacqueline

Chief R&D Officer

Officer
92,018 -20.3%
194.93
US$168,598 		92,018 -20.3% 194.93 US$168,598
2026-04-02 2026-04-01 PlS Planned sale
Zummo Jacqueline

Chief R&D Officer

Officer
22,598 -19.1%
5.26
US$118,865 		22,598 -19.1% 5.26 US$118,865
2026-04-01 2026-04-01 PrS Proposed sale
Zummo Jacqueline

Officer

Officer
23,732
5.26
US$124,826 		23,732 5.26 US$124,826
2026-03-06 2026-03-06 PrS Proposed sale
667, L.P.

Former Affiliate
38,277
5.85
US$223,920 		38,277 5.85 US$223,920
2026-03-06 2026-03-06 PrS Proposed sale
Baker Brothers Life Sciences, L.P.

Former Affiliate
461,723
5.85
US$2,701,080 		461,723 5.85 US$2,701,080
2026-03-04 2026-03-04 PrS Proposed sale
667, L.P.

Former Affiliate
35,173
6.26
US$220,151 		35,173 6.26 US$220,151
2026-03-04 2026-03-04 PrS Proposed sale
Baker Brothers Life Sciences, L.P.

Former Affiliate
424,125
6.26
US$2,654,641 		424,125 6.26 US$2,654,641
2026-02-25 2026-02-25 PrS Proposed sale
667, L.P.

Former Affiliate
78,716
5.81
US$457,046 		78,716 5.81 US$457,046
2026-02-25 2026-02-25 PrS Proposed sale
Baker Brothers Life Sciences, L.P.

Former Affiliate
947,479
5.81
US$5,501,316 		947,479 5.81 US$5,501,316
2026-02-24 2026-02-24 PrS Proposed sale
667, L.P.

Former Affiliate
26,755
6.04
US$161,584 		26,755 6.04 US$161,584
2026-02-24 2026-02-24 PrS Proposed sale
Baker Brothers Life Sciences, L.P.

Former Affiliate
322,039
6.04
US$1,944,922 		322,039 6.04 US$1,944,922
2025-05-16 2025-05-14 B Purchase
3.5
Levy Richard S
Non-Executive Director
20,000 +64.5%
3.19
US$63,800 		20,000 +64.5% 3.19 US$63,800
2025-03-28 2025-03-26 PlS Planned sale
Zummo Jacqueline

Chf Scientific Operations Off

Officer
21,224 -17.7%
4.53
US$96,145 		21,224 -17.7% 4.53 US$96,145
2025-03-26 2025-03-26 PrS Proposed sale
Zummo Jacqueline

Officer

Officer
21,224
4.55
US$96,569 		21,224 4.55 US$96,569
2024-09-12 2024-09-12 S Sale
3.3
Opaleye Management Inc.
Large shareholder
6,500 -12.6%
1.71
US$11,108 		6,500 -12.6% 1.71 US$11,108
2024-09-12 2024-09-12 S Sale
3.3
Opaleye Management Inc.
Large shareholder
119,801 -5.8%
1.71
US$204,728 		119,801 -5.8% 1.71 US$204,728
2024-09-12 2024-09-11 S Sale
3.3
Opaleye Management Inc.
Large shareholder
1,600 -3.0%
1.71
US$2,743 		1,600 -3.0% 1.71 US$2,743
2024-09-12 2024-09-11 S Sale
3.3
Opaleye Management Inc.
Large shareholder
31,000 -1.5%
1.71
US$53,137 		31,000 -1.5% 1.71 US$53,137
2024-09-10 2024-09-10 S Sale
3.3
Opaleye Management Inc.
Large shareholder
1,500 -2.7%
1.77
US$2,654 		1,500 -2.7% 1.77 US$2,654
2024-09-10 2024-09-10 S Sale
3.3
Opaleye Management Inc.
Large shareholder
24,000 -1.1%
1.77
US$42,456 		24,000 -1.1% 1.77 US$42,456
2024-09-10 2024-09-09 S Sale
3.3
Opaleye Management Inc.
Large shareholder
1,900 -3.4%
1.89
US$3,600 		1,900 -3.4% 1.89 US$3,600
2024-09-10 2024-09-09 S Sale
3.3
Opaleye Management Inc.
Large shareholder
34,592 -1.6%
1.89
US$65,541 		34,592 -1.6% 1.89 US$65,541
2024-07-18 2024-07-16 S Sale
3.3
Opaleye Management Inc.
Large shareholder
3,500 -5.8%
2.44
US$8,547 		3,500 -5.8% 2.44 US$8,547
2024-07-18 2024-07-16 S Sale
3.3
Opaleye Management Inc.
Large shareholder
7,896 -0.4%
2.44
US$19,281 		7,896 -0.4% 2.44 US$19,281
2024-07-11 2024-07-11 S Sale
3.3
Opaleye Management Inc.
Large shareholder
15,000 -20.0%
2.40
US$36,051 		15,000 -20.0% 2.40 US$36,051
2024-07-11 2024-07-11 S Sale
3.3
Opaleye Management Inc.
Large shareholder
32,993 -1.5%
2.40
US$79,295 		32,993 -1.5% 2.40 US$79,295
2024-07-11 2024-07-10 S Sale
3.3
Opaleye Management Inc.
Large shareholder
5,000 -6.2%
2.31
US$11,540 		5,000 -6.2% 2.31 US$11,540
2024-07-11 2024-07-10 S Sale
3.3
Opaleye Management Inc.
Large shareholder
13,061 -0.6%
2.31
US$30,145 		13,061 -0.6% 2.31 US$30,145
2024-07-11 2024-07-09 S Sale
3.3
Opaleye Management Inc.
Large shareholder
2,500 -3.0%
2.21
US$5,534 		2,500 -3.0% 2.21 US$5,534
2024-07-11 2024-07-09 S Sale
3.3
Opaleye Management Inc.
Large shareholder
5,997 -0.3%
2.21
US$13,276 		5,997 -0.3% 2.21 US$13,276
2024-07-03 2024-07-01 S Sale
3.3
Opaleye Management Inc.
Large shareholder
2,500 -2.8%
2.12
US$5,308 		2,500 -2.8% 2.12 US$5,308
2024-07-03 2024-07-01 S Sale
3.3
Opaleye Management Inc.
Large shareholder
5,788 -0.3%
2.12
US$12,290 		5,788 -0.3% 2.12 US$12,290
2024-06-28 2024-06-28 S Sale
3.3
Opaleye Management Inc.
Large shareholder
5,000 -5.6%
2.07
US$10,374 		5,000 -5.6% 2.07 US$10,374
2024-06-28 2024-06-28 S Sale
3.3
Opaleye Management Inc.
Large shareholder
12,994 -0.6%
2.07
US$26,960 		12,994 -0.6% 2.07 US$26,960
2024-06-28 2024-06-27 S Sale
3.3
Opaleye Management Inc.
Large shareholder
12,471 -12.2%
2.26
US$28,161 		12,471 -12.2% 2.26 US$28,161
2024-06-28 2024-06-27 S Sale
3.3
Opaleye Management Inc.
Large shareholder
34,103 -1.5%
2.26
US$77,008 		34,103 -1.5% 2.26 US$77,008
2024-06-27 2024-06-25 S Sale
3.3
Opaleye Management Inc.
Large shareholder
6,225 -5.7%
2.26
US$14,057 		6,225 -5.7% 2.26 US$14,057
2024-06-27 2024-06-25 S Sale
3.3
Opaleye Management Inc.
Large shareholder
6,500 -0.3%
2.26
US$14,678 		6,500 -0.3% 2.26 US$14,678
2024-05-31 2024-05-31 S Sale
3.3
Opaleye Management Inc.
Large shareholder
5,824 -5.1%
2.90
US$16,895 		5,824 -5.1% 2.90 US$16,895
2024-05-31 2024-05-30 S Sale
3.3
Opaleye Management Inc.
Large shareholder
9,230 -7.5%
2.94
US$27,113 		9,230 -7.5% 2.94 US$27,113
2024-05-23 2024-05-22 S Sale
3.3
Opaleye Management Inc.
Large shareholder
500 -0.4%
3.00
US$1,501 		500 -0.4% 3.00 US$1,501
2024-05-23 2024-05-22 S Sale
3.3
Opaleye Management Inc.
Large shareholder
9,300 -0.4%
3.02
US$28,095 		9,300 -0.4% 3.02 US$28,095
2024-05-23 2024-05-21 S Sale
3.3
Opaleye Management Inc.
Large shareholder
1,800 -1.4%
3.06
US$5,500 		1,800 -1.4% 3.06 US$5,500
2024-05-23 2024-05-21 S Sale
3.3
Opaleye Management Inc.
Large shareholder
31,200 -1.3%
3.06
US$95,338 		31,200 -1.3% 3.06 US$95,338
2024-05-17 2024-05-17 S Sale
3.3
Opaleye Management Inc.
Large shareholder
1,200 -0.9%
3.06
US$3,673 		1,200 -0.9% 3.06 US$3,673
2024-05-17 2024-05-17 S Sale
3.3
Opaleye Management Inc.
Large shareholder
2,750 -2.1%
3.33
US$9,152 		2,750 -2.1% 3.33 US$9,152
2024-05-17 2024-05-17 S Sale
3.3
Opaleye Management Inc.
Large shareholder
19,685 -0.8%
3.06
US$60,248 		19,685 -0.8% 3.06 US$60,248
2024-05-17 2024-05-17 S Sale
3.3
Opaleye Management Inc.
Large shareholder
47,250 -2.0%
3.33
US$157,253 		47,250 -2.0% 3.33 US$157,253
2024-05-10 2024-05-10 S Sale
3.3
Opaleye Management Inc.
Large shareholder
151,700 -6.0%
3.11
US$472,424 		151,700 -6.0% 3.11 US$472,424
2024-05-10 2024-05-09 S Sale
3.3
Opaleye Management Inc.
Large shareholder
30,600 -1.2%
3.09
US$94,526 		30,600 -1.2% 3.09 US$94,526
2022-09-15 2022-09-15 B Purchase
3.3
Opaleye Management Inc.
Large shareholder
2,300 +1.8%
3.80
US$8,740 		2,300 +1.8% 3.80 US$8,740
2022-09-15 2022-09-15 B Purchase
3.3
Opaleye Management Inc.
Large shareholder
5,000 +0.2%
3.80
US$19,000 		5,000 +0.2% 3.80 US$19,000
2022-09-15 2022-09-14 B Purchase
3.3
Opaleye Management Inc.
Large shareholder
2,500 +2.0%
3.98
US$9,950 		2,500 +2.0% 3.98 US$9,950
2022-09-15 2022-09-14 B Purchase
3.3
Opaleye Management Inc.
Large shareholder
14,100 +0.6%
3.98
US$56,118 		14,100 +0.6% 3.98 US$56,118
2022-08-15 2022-08-11 B Purchase
1.4
Shefferman Jesse

CEO and President

Executive Director
9,065 +1.0%
3.84
US$34,810 		9,065 +1.0% 3.84 US$34,810
2022-07-05 2022-06-30 B Purchase
2.4
BESHAR LUKE M
Non-Executive Director
10,000 +5.3%
3.10
US$31,000 		10,000 +5.3% 3.10 US$31,000
2022-04-08 2022-04-08 B Purchase
3.3
Opaleye Management Inc.
Large shareholder
2,469 +105.4%
4.80
US$11,841 		2,469 +105.4% 4.80 US$11,841
2022-04-08 2022-04-08 B Purchase
3.3
Opaleye Management Inc.
Large shareholder
5,322 +0.2%
4.80
US$25,523 		5,322 +0.2% 4.80 US$25,523
2022-04-08 2022-04-07 B Purchase
3.3
Opaleye Management Inc.
Large shareholder
1,000 +0.8%
4.74
US$4,743 		1,000 +0.8% 4.74 US$4,743
2022-04-08 2022-04-07 B Purchase
3.3
Opaleye Management Inc.
Large shareholder
1,345 +0.1%
4.74
US$6,380 		1,345 +0.1% 4.74 US$6,380
2022-03-16 2022-03-14 B Purchase
2.4
BESHAR LUKE M
Non-Executive Director
10,000 +5.6%
4.25
US$42,500 		10,000 +5.6% 4.25 US$42,500
2022-03-14 2022-03-10 B Purchase
2.4
BESHAR LUKE M
Non-Executive Director
10,000 +6.0%
4.46
US$44,555 		10,000 +6.0% 4.46 US$44,555
2022-01-31 2022-01-28 B Purchase
3.3
Opaleye Management Inc.
Large shareholder
4,031 +3.4%
4.96
US$20,007 		4,031 +3.4% 4.96 US$20,007
2022-01-31 2022-01-28 B Purchase
3.3
Opaleye Management Inc.
Large shareholder
20,000 +0.8%
4.96
US$99,264 		20,000 +0.8% 4.96 US$99,264
2021-12-22 2021-12-20 B Purchase
3.3
Opaleye Management Inc.
Large shareholder
703 +0.0%
6.49
US$4,562 		703 +0.0% 6.49 US$4,562
2021-12-20 2021-12-17 B Purchase
3.3
Opaleye Management Inc.
Large shareholder
490 +0.5%
6.60
US$3,234 		490 +0.5% 6.60 US$3,234
2021-12-20 2021-12-17 B Purchase
3.3
Opaleye Management Inc.
Large shareholder
2,300 +0.1%
6.60
US$15,180 		2,300 +0.1% 6.60 US$15,180
2021-12-20 2021-12-16 B Purchase
3.3
Opaleye Management Inc.
Large shareholder
1,063 +1.0%
6.41
US$6,815 		1,063 +1.0% 6.41 US$6,815
2021-12-20 2021-12-16 B Purchase
3.3
Opaleye Management Inc.
Large shareholder
6,500 +0.3%
6.41
US$41,670 		6,500 +0.3% 6.41 US$41,670
2021-11-19 2021-11-18 B Purchase
3.3
Opaleye Management Inc.
Large shareholder
1,000 +1.0%
6.98
US$6,980 		1,000 +1.0% 6.98 US$6,980
2021-11-19 2021-11-18 B Purchase
3.3
Opaleye Management Inc.
Large shareholder
14,206 +0.6%
6.98
US$99,151 		14,206 +0.6% 6.98 US$99,151
2021-11-19 2021-11-17 B Purchase
3.3
Opaleye Management Inc.
Large shareholder
1,090 +1.1%
6.98
US$7,608 		1,090 +1.1% 6.98 US$7,608
2021-11-19 2021-11-17 B Purchase
3.3
Opaleye Management Inc.
Large shareholder
8,028 +0.3%
6.98
US$56,035 		8,028 +0.3% 6.98 US$56,035
Explore more

More insider trading research around Protara Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America